What have we learned from risk-reducing salpingo-oophorectomy?

Journal of the National Cancer Institute

Volumn 101, Issue 2, 2009, Pages 70-71

  Greene, Mark H ^a   Mai, Phuong L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN;

BREAST CANCER; CANCER GENETICS; CANCER MORTALITY; CANCER RISK; EDITORIAL; GENE MUTATION; HUMAN; MEDICAL INFORMATION; ONCOGENE; OUTCOME ASSESSMENT; OVARY CANCER; PHENOTYPE; PRIORITY JOURNAL; PUBLISHING; RISK REDUCTION; SALPINGOOOPHORECTOMY; UTERINE TUBE CARCINOMA; BREAST TUMOR; DECISION MAKING; EVIDENCE BASED MEDICINE; FEMALE; GENETICS; META ANALYSIS; METHODOLOGY; MUTATION; NOTE; OVARIECTOMY; OVARY TUMOR; PRIMARY PREVENTION; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; TUMOR SUPPRESSOR GENE; UNCERTAINTY; UTERINE TUBE;

BREAST NEOPLASMS; DECISION MAKING; EVIDENCE-BASED MEDICINE; FALLOPIAN TUBES; FEMALE; GENES, BRCA1; GENES, BRCA2; GERM-LINE MUTATION; HUMANS; META-ANALYSIS AS TOPIC; OVARIAN NEOPLASMS; OVARIECTOMY; PRIMARY PREVENTION; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; UNCERTAINTY;

EID: 59049093043     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djn476     Document Type: Editorial

References (10)

1. Rebbeck TR, Kauff ND, Domchek SM. Meta-analysis of risk-reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst. 2008;101(2):80-87.
2. Han PKJ, Moser RP, Klein WMP. Perceived ambiguity about cancer prevention recommendations: associations with cancer-related perceptions and behaviours in a US population survey. Health Expect. 2007;10(4):321-336.
3. Han PKJ, Kobrin SC, Klein WMP, Davis WW, Michael Stefanek M, Taplin SH. Perceived ambiguity about screening mammography recommendations: association with future mammography uptake and perceptions. Cancer Epidemiol Biomarkers Prev. 2007;16(3):458-466.
4. Tobacman JK, Greene MH, Tucker MA, Costa J, Kase R, Fraumeni JF Jr. Intra-abdominal carcinomatosis following prophylactic oophorectomy in ovarian cancer-prone families. Lancet. 1982;2(8302):795-797.
5. Levine DA, Argenta PA, Yee CJ, et al. Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations. J Clin Oncol. 2003;21(22):4222-4227.
6. Greene MH, Piedmonte M, Alberts D, et al. GOG-199: a prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer. Design and baseline characteristics - a GOG study. Cancer Epidemiol Biomarkers Prev. 2008;17(3):594-604.
7. Sherman ME, Lee JS, Burks RT, Struewing JP, Kurman RJ, Hartge P. Histopathologic features of ovaries at increased risk for carcinoma - a case-control analysis. Int J Gynecol Pathol. 1999;18(2):151-157.
8. Carlson JW, Miron A, Jarboe EA, et al. Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention. J Clin Oncol. 2008;26(25):4160-4165.
9. Kramer J, Velazquez I, Chen BS, Rosenberg P, Struewing J, Greene MH. Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers. J Clin Oncol. 2005;23(34):8629-8635.
10. Domchek SM, Friebel TM, Neuhausen SL, et al. Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Lancet Oncol. 2006;7(3):223-229.